Abstract
Drug therapy is the commonest cause of hyperprolactinaemia in clinical practice. It may present with symptoms and signs, or be subclinical. Whilst the phenothiazine and butyrophenone antipsychotic drugs used to be the most common causes of drug-induced hyperprolactinaemia, it is now more often encountered in patients taking specific serotonin reuptake inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
